Dr. Ana Vega

Dr. Ana Vega Gliemmo is the Principal Investigator of the Cancer Genetics and Rare Diseases Group at the Santiago de Compostela Health Research Institute (IDIS) and a senior researcher within the Galician Health Service (Sergas) network. Her research program focuses on translational oncology, characterization of hereditary cancer susceptibility variants, and computational modeling for gene splicing predictions. She earned her PhD in Pharmacy from the University of Santiago de Compostela, receiving maximum honors for her doctoral thesis in clinical genetics. Dr. Vega Gliemmo leads multi-institutional projects bridging molecular diagnostics and clinical application. 

She has authored over 60 papers published in high-impact journals and has participated in more than 25 research projects, serving as the Principal Investigator for ten of them. She has received numerous research awards, notably the AEGH Prize, which recognizes the best career achievements by a young researcher. 

She is actively involved in various National and International Research Consortia, with notable participation in ENIGMA (Evidence-based Network for the Interpretation of Germline Mutant Alleles), PRACTICAL (Prostate Cancer Association Group to Investigate Cancer Associated Alterations in the Genome), and the RADIOGENOMIC CONSORTIUM, where she serves as the representative for Spain.